Intestinal Disorders

Top Story

Apraglutide receives orphan drug designation for short bowel syndrome

January 5, 2019

ArTara advances trial of intestinal failure-associated liver disease therapy

January 2, 2019
ArTara Therapeutics has completed an end-of-phase 2 meeting with the FDA to discuss a phase 3 study of intravenous choline chloride substrate replacement for patients…
FDA News

FDA accepts new drug application filing for expanded use of Gattex for short bowel syndrome

November 17, 2018
The FDA has accepted the filing of a new drug application to extend the use of Gattex for injection in children aged 1 to 17 years with short bowel syndrome, according…

Pediatricians explore ways to use virtual reality in practice

Infectious Diseases in Children, October 2018
Researchers and pediatric specialists are working to find new, innovative ways to use virtual reality to improve patient care. Kate Donovan, PhD, MBA, MS, clinical…
More Headlines »

Therapeutic Drug Monitoring in Crohn’s Disease: Personalized Approaches for Treatment Optimization

This activity is supported by an educational grant from UCB, Inc.

Despite the proven therapeutic efficacy of anti-tumor necrosis factor (TNF) agents, treatment failures due to primary…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News Coverage

VIDEO: Several new drug treatments benefit patients with IBS

June 4, 2015
More »